Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

BioAge Labs (BIOA) Cost of Revenue (2024 - 2025)

BioAge Labs (BIOA) has disclosed Cost of Revenue for 2 consecutive years, with $18.6 million as the latest value for Q4 2025.

  • Quarterly Cost of Revenue rose 39.35% to $18.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $49.4 million through Dec 2025, up 33.17% year-over-year, with the annual reading at $49.4 million for FY2025, 33.17% up from the prior year.
  • Cost of Revenue hit $18.6 million in Q4 2025 for BioAge Labs, up from $12.2 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $18.6 million in Q4 2025 to a low of $4.6 million in Q1 2024.